Diaphragmatic tumors, whether benign or malignant, may not generally reveal any symptoms in the early phase and may be found accidentally. During a pre-employment physical examination, a 20-year-old woman wasfound to have anabnormal shadow onthe leftdiaphragm. An X-ray film, computed tomography andultrasonography showed a giant mass on the left side, to the rear of the heart. She underwent surgery via a left thoraco-abdominal approach. The lesion was found to arise from the leftdiaphragm, and multiple disseminated lesions were scattered in the left thoracic cavity. Histological examination showed many large, oxyphilic rhabdoid cells between diffusely proliferating, spindle-shaped cells, and the tumor was subsequently diagnosed as a pleomorphic rhabdomyosarcoma of the diaphragm, of which the location and histological type were veryrare. Despite adjuvant therapy, chest X-ray and CT revealed increasing tumorgrowth in the left cavity and she died one year after surgery.
INTRODUCTION
Primary diaphragmatic tumors, albeit rare, include a variety of tumors such as bronchial, mesothelial and teratoid cysts, fibrosarcoma, lipoma, fibroma, neurofibroma and rhabdomyosarcoma (1, 2) . This makes it difficult to diagnose tumors located in this area correctly, despite recent advances in diagnostic imaging modalities (3) (4) (5) (6) (7) such as ultrasonography (US) (3, 5) and CT (3, 6, 7) . In this paper, a patient with rhabdomyosarcoma of the left diaphragm is reported and particular attention is paid to the incidence, symptoms and treatment of the tumor.
CASE REPORT
A 20-year-old woman was admitted to our hospital with an abnormal shadow on the left diaphragm revealed on a chest X-ray film taken during a pre-employment physical examination. A hard tumor, 15 x 15 em in size, was palpable in the eighth intercostal space at the intrascapular region. A chest X-ray revealed a mass on the left side, to the rear of the heart (Fig. 1) .
Received May 9, 1997; accepted October 1, 1997 For reprints and all correspondence: Yutaka Midorikawa, Second Department of Surgery, Faculty of Medicine, University of Tokyo, 7-3-1, Hongo, Bunkyo-ku, Tokyo 113, Japan Abbreviation: US, ultrasonography A CT scan of the chest demonstrated a heterogeneous enhanced tumor of the left diaphragm (Fig. 2a) , US revealed a heterogeneous mass (11.1 x 11.5em) with a solid and cystic pattern ( Fig.   2b ) and angiography demonstrated a hypovascular tumor. Under a diagnosis of either a retroperitoneal or a diaphragmatic tumor without a definite diagnosis as being benign or malignant, the patient underwent surgery via a left thoraco-abdominal approach.
A hard mass, 15 x 14 x 3.5 ern, arising from the left diaphragm had invaded the lower lobe of the left lung and pleura and multiple disseminated lesions in the pericardium and pleura were found. The main tumor and its diaphragmatic lesions were resected, but the other lesions were unresectable. Pathological findings of the specimen led to the lesion being diagnosed as a rhabdomyosarcoma of the diaphragm, clinical stage group IV, as defined by the Intergroup Rhabdomyosarcoma Study. Although the operative procedure was palliative, the patient did not agree to undergo severe chemotherapy because of its side effects such as alopecia, nausea and anorexia, so a chemotherapy regimen of relatively low dose (vincristine 1.5 mg/m 2 x 12, actinomycin D 0.010 mg/kg x 4 and cyclophosphamide 6 mg/kg x 4) was instituted three weeks later with simultaneous radiotherapy (2 Gy x 21 sessions). After discharge, chest X-ray and CT revealed rapid increasing tumor growth in the left thoracic cavity and the patient developed progressive dysphagia, cough and pleural effusion, and died one year later. 
DISCUSSION
Rhabdom yosarcoma is quite a rare primary diaphragmatic tumor. In 1965, Wiener and Chou reviewed 71 cases of primary tumors of the diaphragm reported from 1886 to 1963 and only two had rhabdomyosarcomas ( I). In 1971, Olafsson et al. described another 14 cases of primary diaphragmatic tumors reported from 1964 to 1968 (2) , and between 1969 and 1995,55 such cases, including six of rhabdomyosarcoma, were reported in the literature. to the best of our knowledge (Table 1) . Overall, only eight patients (5.7%) were diagnosed as having rhabdomyosarcoma of the diaphragm (3-10) ( Table 2 ). Although some patients with rhabdomyosarcoma of the diaphragm were reported to be asymptomatic, most had several symptoms, such as epigastralgia, pain in the lower part of the chest, anorexia, vomiting, dysphagia, cough and dyspnea (Table 2). The presence of diaphragmatic tumors can be demonstrated using several diagnostic imaging modalities. A chest X-ray study may reveal an elevated hemidiaphragm, a localized diaphragmatic hump or pleural effusion. CT and US usually visualize a Histologically, rhabdomyosarcoma is divided into three major categories: embryonal, alveolar and pleomorphic. Embryonal rhabdomyosarcoma, the most common type, is regarded as a high-grade malignant tumor and occurs most frequently in the first years of life. Alveolar rhabdomyosarcoma accounts for 10-20% of all cases and occurs mainly in adolescents, and pleomorphic rhabdomyosarcoma, the diagnosis in our patient, is believed to be very rare, occurs predominantly in the extremities of adults and its prognosis is generally poor (11).
When a diaphragmatic tumor cannot be diagnosed as benign, as in our patient, it should be resected, because it may be malignant: the ratio of malignant to benign tumors is about 3:2 (Table 1) . A thoraco-abdominal approach may be the most useful for exploring both the abdominal and thoracic cavities. If possible, the lesion should be completely resected, including the lung, pleura and chest wall invaded by the tumor. A variety of techniques using prosthetic materials have been advocated for reconstruction of the chest wall and diaphragm after major en-bloc resection, but as infection or rejection of the prosthetic patch may occur, some authors have recommended using various autologous patches. When rhabdomyosarcoma is diagnosed after surgical resection, the patient should receive adjuvant chemotherapy comprising vincristine, actinomycin D and cyclophosphamide with or without radiotherapy, depending on the clinical stage defined by the Intergroup Rhabdomyosarcoma Study (12) . This protocol on rhabdomyosarcomas developing in other organs, such as the head and neck, genito-urinary tract and extremities, is usually effective, at least initially, but its effect on rhabdomyosarcoma of the diaphragm is unknown. Our patient was young and a cosmetic problem and side effects stopped her from agreeing to undergo severe chemotherapy. Consequently, treatment was ineffective.
In summary, we have reported a patient with an asymptomatic rhabdomyosarcoma of the diaphragm. As it is difficult to diagnose diaphragmatic tumors, some of which are malignant, whenever one is found, surgical treatment should be carried out. This should be followed, if necessary, by adjuvant therapy.
